Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0023418 (leukemia)
 93,477 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

DNA methylation is a type of chemical modification of DNA that adds a methyl group to DNA at the fifth carbon of the cytosine pyrimidine ring. In normal cells, methylation of CpG dinucleotides is extensively found across the genome. However, specific DNA regions known as the CpG islands, short CpG dinucleotide-rich stretches (500 bp - 2000bp), are commonly unmethylated. During tumorigenesis, on the other hand, global de-methylation and CpG island hypermethylation are widely observed. De novo hypermethylation at CpG dinucleotides is typically associated with loss of expression of flanking genes, thus it is believed to be an alternative to mutation and deletion in the inactivation of tumor suppressor genes. In this paper, we report that sequences flanking CpG sites can be used for predicting DNA methylation levels. DNA methylation levels were measured by utilizing a new high throughput sequencing technology (454) to sequence bisulfite treated DNA from four types of primary leukemia and lymphoma cells and normal peripheral blood lymphocytes. After measuring methylation levels at each CpG site, we used 30 bp flanking sequences to characterize methylation susceptibility in terms of character compositions and built predictive models for DNA methylation susceptibility, achieving up to 75% prediction accuracy in 10-fold cross validation tests. Our study is first of its kind to build predictive models for methylation susceptibility by utilizing CpG site specific methylation levels.
Pac Symp Biocomput 2008
PMID:Predicting DNA methylation susceptibility using CpG flanking sequences. 1822 96

This study was conducted with the objective of providing the pattern of cancer distribution from a hospital based tumour registry at CMH, Multan, in comparison with patterns from other National Studies. The retrospective study of malignant tumours recorded at the pathology department from 2002-2007 featured analysis in terms of age group, gender and type of tumour. Over the six year period the total number of malignancies was 930 with a male to female ratio of 1.4:1. The common tumours in males, in order of decreasing frequency were leukaemia, prostate cancer, urinary bladder cancer, skin cancer and lymphomas. In females they were leukaemia, breast cancer, skin cancer, gallbladder cancer and lymphomas. In both sexes, the most common malignancy was leukaemia, which is contrary to other studies, pointing to a possible link with extensive use of pesticides and other agricultural chemicals in this region of the country.
Asian Pac J Cancer Prev
PMID:Cancer data analysis in the pathology department, combined military hospital, Multan, Pakistan 2002-2007. 1925 58

Cancer incidence data collected by the Guam Cancer Registry for the period 1998 through 2002 were analyzed by cancer site, age, and ethnicity. Ethnicity and site specific age-adjusted cancer incidence rates for Guam residents were calculated utilizing Guam 2000 census data and the U.S. 2000 standard population and were compared to U.S. 2000 data. Age-adjusted total cancer incidence rates per 100,000 population for the major ethnic groups represented on Guam were generally lower than U.S. averages (the exception was the Caucasian group which was higher). Some highlights include: 1). Chamorros (the indigenous people of the Mariana Islands) living on Guam had a slightly lower total cancer incidence rate than the total U.S. population (406.8/100,000 vs. 478.6 U.S.). Chamorros had high age-adjusted incidence rates for cancers of the mouth and pharynx (24.4 vs. U.S. 10.7), nasopharynx (13.9 vs. 0.6 U.S.), liver (13.2 vs. 5.2 U.S.), and cervix (16.2 vs. 9.6 U.S.). Rates for prostate cancer ( 103.9 vs. 167.7 U.S.), female breast (115.9 vs. 130.9 U.S.), ovary (7.0 vs. 14.2 U.S.), colon-rectum-anus (44.3 vs. 56.9 U.S.), leukemia (11.0 vs. 12.6 U.S.), and non-Hodgkin lymphoma (7.0 vs. 18.9 U.S.) were all lower than U.S. rates. 2). Filipinos living on Guam had high age-adjusted incidence rates for cancers of the nasopharynx (5.1), and liver (9.6). Filipinos had low age-adjusted incidence rates for all cancers (215.7), cancers of the mouth and pharynx when NPC was excluded (4.8), lung and bronchus (35.6 vs. U.S. 70.1), pancreas (1.7 vs. U.S. 11.1), colon-rectum-anus (37.1), female breast (60.7), prostate (46.1), leukemia (4.7), and non-Hodgkin lymphoma (8.4). 3). Micronesians other than Chamorros had the highest age-adjusted incidence rates for cancers of the lung and bronchus (111.5), liver (39.4), and cervix (27.4). Micronesians had low age-adjusted incidence rates for cancers of the colon-rectum-anus (4.1), female breast (35.0), prostate (78.4), leukemia (6.3), and non-Hodgkin lymphoma (6.6). 4). Asians had low total age-adjusted cancer incidence rates (149.7) but had high nasopharyngeal cancer (5.4) and liver (10.7) cancer rates. Asians had low rates of cancers of the mouth and pharynx when nasopharyngeal cancers were excluded (1.4), lung and bronchus cancers (25.8), colon-rectum-anus (26.3), female breast (63.0), ovary (no cases recorded), prostate (31.3), leukemia (5.0) and non-Hodgkin lymphoma (4.9). 5).Caucasians residing on Guam had high age-adjusted cancer incidence rates for cancers of the colon-rectum-anus (91.4), female breast (148.6), ovary (34.7), and leukemia (17.7). Caucasians had low age-adjusted cancer incidence rates for nasopharyngeal cancer (no cases recorded), liver (4.0) and non-Hodgkin lymphoma (7.9). Suggestions are made for further research to explain the ethnic disparitiesin cancer incidence observed on Guam and to develop strategies for ameliorating these disparities.
Asian Pac J Cancer Prev
PMID:Ethnic disparities in cancer incidence among residents of Guam. 1946 25

There have been few studies on cancer incidence and survival among children in Japan. Childhood cancer cases in Hiroshima City can be ascertained almost perfectly in terms of completeness and validity as both a population-based cancer registry and a tissue registry cover the whole area. We report here recent incidence and survival of childhood cancer in Hiroshima City. Subjects were cancer patients less than 15 years of age in Hiroshima City registered in the Hiroshima City Cancer Registry and/or the Hiroshima Prefecture Tumor Registry (tissue registry) between 1998 and 2000. Cancer incidence in Hiroshima City was calculated for 12 diagnostic groups according to the International Classification of Childhood Cancer, and compared with general incidence in Japan. Five-year survival was calculated by the Kaplan-Meier method. There were 63 children who had a cancer newly diagnosed during 1998-2000, with only one death-certificate-only case (1.6%). Age-standardized incidence rates (per million) were 144.3 for boys and 93.9 for girls. Leukemia was the most frequent (29%) among the 12 diagnostic groups. There were 13 cancer deaths during this period and five-year survival was 79% (95% Confidence Interval: 67%-87%). Childhood cancer incidence was slightly higher than that for all of Japan, but the relative distribution of patients by diagnostic group was compatible with the general pattern. Both of these observations might be due to the high quality of the tumor and tissue registries.
Asian Pac J Cancer Prev
PMID:Incidence and survival of childhood cancer cases diagnosed between 1998 and 2000 in Hiroshima City, Japan. 1982 93

Leukemias are the commonest childhood malignancy in West Bengal. This study was undertaken on 75 children at NRS Medical College, West Bengal to determine the distribution of signs and symptoms of leukemia and to identify unusual clinical features. After obtaining clinical history, physical examination, hematological and radiological investigations were performed. Acute lymphoblastic leukaemia (ALL, 72%) was the commonest followed by acute myeloid leukaemia (AML, 18.7%). Common symptoms and signs were fever (85.3%), pallor (64%), hepatomegaly (72%), splenomegaly (60%) and lymphadenopathy (50.7%). The uncommon signs and symptoms were abdominal pain (9.3%), joint pain (9.3%), hematemesis and malena (8%), diarrhea (5.3%), proptosis (2 cases), dysphagia, mediastinal mass and parotid swelling (1 case each). Uncommon clinical presentations lead to delay in diagnosis in some cases. Awareness of uncommon signs and symptoms of childhood leukemia together with laboratory tests may help in earlier diagnosis and proper management of the patients.
Asian Pac J Cancer Prev 2009
PMID:Childhood acute leukemia in West Bengal, India with an emphasis on uncommon clinical features. 2059 69

The population-based Aden Cancer Registry (ACR) started its activities in 1997. The objective of the registry is to establish a reliable magnitude of cancer in the area covered and the first report was published in 2003. The present article describes data from the second report of cancer incidence over a five year period (2002-2006). Internationally accepted standardized cancer registration methodologies described by IACR and IARC were used. CanReg-4 using ICDO-3 and ICD-10 were applied in the data processing and analysis. Results showed no difference in the overall incidence between the males and females (ratio was 0.83:1) and age standardized rate s(ASR) per 100,000 inhabitants were 30.2 and 31.1. The five most common cancers were breast cancer, leukemia, non-Hodgkin's lymphomas (NH lymphoma), brain cancer and Hodgkin's disease (16.6%, 12.6%, 7.8%, 5.2% and 4.4%, respectively). Among males, leukemia was the first followed by NH lymphoma, Hodgkin's disease, brain and liver. In females, breast was the first, then leukemia, NH lymphoma, thyroid and brain cancer. The highest ASR for males (145 per 100,00 inhabitants) was observed at age 70-74 years whereas for females, two peaks (each 105 per 100,000 inhabitants) were equally noticed at age 60-64 and 70-74 years. Generally, females showed equal or higher incidence compared to males until age 55-59 where males reported higher incidence. The overall pattern of cancer incidence in this report is not much different from that in the previous report. Furthermore, the report generally indicates that the pattern of the most common registered cancer bears some similarities with the adjacent Gulf Cooperation Council States with which we share many characteristics, despite differences that warrant further investigation.
Asian Pac J Cancer Prev 2010
PMID:Five years cancer incidence in Aden Cancer Registry, Yemen (2002-2006). 2084 42

In the last several decades, there have been major advances in the treatment of pediatric cancers. 5 year survival of children with acute lymphoblastic leukemia has increased from 25% to 80%. Early stages of non -Hodgkin's, Hodgkin's and Wilms tumors all have more than 90% long term survival. In addition to improving survival, the comprehensive care of children with cancer must offer total care including special emphasis on pain management and psychosocial support by a multidisciplinary team. Pain considerations in children are unique and differ from those in adults. For example, bone pain is often one of the presenting symptoms of leukemia in children, but can be mistaken for growing pain or labeled psychological. Bone pain is also a prominent symptom in late stage neuroblastoma, and of course in bone tumors. The American Medical Association and National Cancer Institute promote the absence of pain as a patient right and a marker of good clinical care and a quality of care issue. Pain due to disease burden responds dramatically to chemotherapy and the uninitiated are often surprised by the sudden increase in activity and playfulness of children undergoing induction chemotherapy. History and physical data, with special assessment of pain should be part of the medical record of all children.
Asian Pac J Cancer Prev 2010
PMID:Effective management of pain in pediatric hematology and oncology. 2084 57

The multidrug resistance (MDR1) gene product P-glycoprotein is a membrane bound protein that functions as an ATP-dependent efflux pump, transporting exogenous and endogenous substrates from the cells. Since it plays an important role in chemotherapy, there is an increasing interest in the possible significance of genetic variation in MDR1. Our main objective was to study the MDR1gene polymorphism at C3435T with reference to development and progression of acute leukemia. The present study included 290 acute leukemia cases, comprising of 147 acute lymphocytic leukemia (ALL), 143 acute myeloid leukemia and 249 age-sex matched control samples for the analysis of MDR1 C3435T polymorphism, by the PCR-RFLP method. The MDR1 genotype distribution revealed an elevated frequency of the TT genotype in ALL cases (51.7%) as compared to controls (28.9%), whereas AML group did not show any association. The mean white blood cell count, blast% and LDH levels were increased in ALL patients with the CC genotype. No deviation was observed with respect to hematoglobin, platelet count and disease free survival in ALL patients. The association of CC genotype with clinical variables in ALL indicated that the CC genotype with high expression might be eliminating antileukemic drugs (anthracyclines, Daunorubicin, Vincristeine, Mitoxanthrone) which are P-gp substrates, leading to lower intra cellular drug concentrations and a poor prognosis. Such an association with the CC genotype was not observed in AML. In conclusion, these results suggested that the MDR1 TT genotype might influence risk of development of acute lympoblastic leukemia and the CC genotype might be linked to a poor prognosis of ALL.
Asian Pac J Cancer Prev 2010
PMID:Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India. 2113 25

The increasing magnitude of childhood cancer has become a threatening problem in developing countries like India. Data from the Population Based Cancer Registry (PBCR) of Chittaranjan National Cancer Institute (CNCI), Kolkata during 1997 to 2004 were here analyzed. CNCI receives patients from West Bengal as well as other neighboring states and countries. Childhood cancer was found to account for 2.21% of all cancers registered in this period. Crude and age adjusted rates were higher among boys than girls, with leukemia as the commonest (36.8%) followed by lymphomas (14.8%) and soft tissue tumors (8.0%). Chemotherapy was the major modality of treatment given, followed by radiotherapy and surgery. The study provides useful information on the prevalence and management protocols of childhood cancer in this part of eastern India.
Asian Pac J Cancer Prev 2010
PMID:Childhood cancer burden in part of eastern India--Population Based Cancer Registry data for Kolkata (1997-2004). 2119 78

Various factors have recently prompted a re-evaluation of the role of non-anthracycline regimens in early stage breast cancer (ESBC). Since 1990 anthracyclines have been a key component of chemotherapy regimens. However, there is increased understanding of the long-term, irreversible toxicities associated with these therapies, including cardiac failure and secondary leukemia. The development of the taxanes in the 1990s led to new adjuvant chemotherapy regimens and trials of various combinations in an effort to further increase survival and reduce toxicity. Concerns about cardiac toxicity were reinforced with the emergence of trastuzumab for the treatment of HER2-positive breast cancer. Trastuzumab alone causes cardiac toxicity and increases the risk of cardiac toxicity when combined with anthracyclines. These data, combined with recent results demonstrating the efficacy of non-anthracycline regimens in various disease settings, have generated interest in utilizing these therapies in patients with both HER2-positive and -negative tumors. This review outlines the evidence for the use of non-anthracycline adjuvant regimens in ESBC, including cyclophosphamide, methotrexate and 5-fluoruoracil, docetaxel, carboplatin and trastuzumab and docetaxel and cyclophosphamide, which have demonstrated equivalent efficacy and reduced toxicity compared to anthracycline-based regimens in various trials. The review also examines evidence for the use of non-anthracycline regimens in patients who previously had restricted access to these therapies due to their negative lymph node status. The wider availability of these regimens increases options when deciding upon adjuvant chemotherapy for patients with ESBC, especially in patients with a high risk of cardiac toxicity.
Asia Pac J Clin Oncol 2011 Mar
PMID:Use of non-anthracycline regimens in early stage breast cancer in Australia. 2133 44


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>